Danaher Corp
DHRToday
+2.42%
5 Days
+5.02%
1 Month
+7.33%
6 Months
-5.47%
Year to Date
-10.55%
1 Year
+2.09%
Thermo Fisher Scientific Inc Stock (TMO) Closed Up by 3.20% on Jul 28: Drivers Behind the Movement
• Thermo Fisher exceeded quarterly earnings estimates and raised full-year organic revenue guidance. • Increased pharmaceutical capital expenditure and demand for clinical services boosted the company's backlog. • Technical indicators suggest a buy signal with an average analyst price target of $634.52.
Stryker Corp Stock (SYK) Closed Up by 3.21% on Jul 23: Drivers Behind the Movement
• Stryker’s second-quarter earnings exceeded analyst expectations with growth in MedSurg and Neurotechnology. • Management raised full-year earnings guidance citing strong demand and elective procedure recovery. • Analysts increased price targets following positive performance and consistent robotic technology market expansion.
Danaher Corp Stock (DHR) Moved Up by 6.78% on Jul 23: What Signal Does It Send?
• Danaher’s quarterly earnings surpassed analyst expectations, driving a rise in the company’s stock price. • Bioprocessing demand has normalized, signaling a recovery in the company’s biotechnology and life sciences segments. • Management raised full-year earnings and revenue guidance, citing sustainable growth in core business units.
Thermo Fisher Scientific Inc Stock (TMO) Moved Up by 9.89% on Jul 23: A Full Analysis
• Thermo Fisher Q2 2026 results exceeded expectations amid bioprocessing recovery and inventory normalization. • Management raised full-year earnings guidance following strong growth in clinical research and diagnostics. • Analysts issued multiple buy ratings with an average price target of $603.15.
Unitedhealth Group Inc Stock (UNH) Moved Up by 3.02% on Jul 21: Drivers Behind the Movement
• UnitedHealth reported strong quarterly earnings driven by growth in its Optum health services segment. • Stable Medicare Advantage reimbursement rates have improved sentiment toward the managed care sector. • A resilient labor market and cooling inflation are supporting UnitedHealth's commercial insurance revenue.
Abbott Laboratories Stock (ABT) Moved Up by 3.12% on Jun 25: A Full Analysis
• Abbott partnered with ALZpath to develop a blood-based Alzheimer’s disease diagnostic test. • Strong FreeStyle Libre sales and clinical trial data drive growth in medical devices. • Analysts maintain bullish ratings, citing dividend history and recent undervaluation of the stock.
Danaher Corp's Score
Media Coverage
Analyst Rating
Danaher Corp Technical Analysis
Technical Indicators
Summary
Moving Average
Financial Indicators
Earnings
Danaher Corp Profile
Ownership
| Shareholders | Proportion |
|---|---|
| Rales (Steven M) | 5.97% |
| Vanguard Capital Management, LLC | 5.81% |
| Rales (Mitchell P) | 4.66% |
| BlackRock Institutional Trust Company, N.A. | 4.12% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 46.09% |
| Investment Advisor/Hedge Fund | 25.78% |
| Individual Investor | 10.69% |
| Hedge Fund | 2.99% |
Related Instruments
Popular Instruments
